###begin article-title 0
###xml 8 21 8 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus</italic>
###xml 91 96 <span type="species:ncbi:9606">human</span>
Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5
###end article-title 0
###begin p 1
###xml 8 21 8 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus</italic>
###xml 83 88 <span type="species:ncbi:9606">human</span>
###xml 336 341 <span type="species:ncbi:9606">human</span>
###xml 916 921 <span type="species:ncbi:9606">human</span>
Group B Streptococcus (GBS) is a leading cause of invasive bacterial infections in human newborns. A key GBS virulence factor is its capsular polysaccharide (CPS), displaying terminal sialic acid (Sia) residues which block deposition and activation of complement on the bacterial surface. We recently demonstrated that GBS Sia can bind human CD33-related Sia-recognizing immunoglobulin (Ig) superfamily lectins (hCD33rSiglecs), a family of inhibitory receptors expressed on the surface of leukocytes. We report the unexpected discovery that certain GBS strains may bind one such receptor, hSiglec-5, in a Sia-independent manner, via the cell wall-anchored beta protein, resulting in recruitment of SHP protein tyrosine phosphatases. Using a panel of WT and mutant GBS strains together with Siglec-expressing cells and soluble Siglec-Fc chimeras, we show that GBS beta protein binding to Siglec-5 functions to impair human leukocyte phagocytosis, oxidative burst, and extracellular trap production, promoting bacterial survival. We conclude that protein-mediated functional engagement of an inhibitory host lectin receptor promotes bacterial innate immune evasion.
###end p 1
###begin p 2
###xml 8 21 8 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus</italic>
###xml 90 109 90 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">Dermer et al., 2004</xref>
###xml 219 220 215 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 340 351 336 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Varki, 2007</xref>
###xml 533 534 529 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">N</italic>
###xml 633 658 629 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">Paoletti and Kasper, 2003</xref>
###xml 814 828 810 824 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Pangburn, 2000</xref>
###xml 968 988 964 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">Marques et al., 1992</xref>
###xml 1063 1083 1059 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">Wessels et al., 1989</xref>
###xml 74 79 <span type="species:ncbi:9606">human</span>
###xml 327 332 <span type="species:ncbi:9606">human</span>
Group B Streptococcus (GBS) is a common cause of sepsis and meningitis in human newborns (Dermer et al., 2004). The GBS capsular polysaccharide (CPS) is a critical virulence factor containing a terminal alpha2-3-linked N-acetylneuraminic acid, identical to the most common sialic acid (Sia) capping many surface glycans on all human cells (Varki, 2007). To date, structures of nine antigenically distinct GBS CPS have been described (serotypes Ia, Ib, and II-VIII), each composed of unique arrangements of galactose, glucose, and/or N-acetylglucosamine but invariantly possessing Sia on the branching terminus of the repeating unit (Paoletti and Kasper, 2003). By increasing affinity of serum factor H for C3b and accelerating intrinsic decay of the C3 convertase, host Sia counterregulates complement activation (Pangburn, 2000). Likewise, by decorating its own surface with Sia, GBS creates a nonactivating environment restricting alternative complement deposition (Marques et al., 1992), impairing opsonophagocytic clearance and promoting disease progression (Wessels et al., 1989).
###end p 2
###begin p 3
###xml 204 226 204 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Varki and Angata, 2006</xref>
###xml 228 248 228 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Crocker et al., 2007</xref>
###xml 250 261 250 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">Varki, 2007</xref>
###xml 435 455 435 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Crocker et al., 2007</xref>
###xml 674 694 674 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Crocker et al., 2007</xref>
###xml 964 988 964 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">Ravetch and Lanier, 2000</xref>
###xml 1139 1158 1139 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">Taylor et al., 2000</xref>
###xml 1249 1267 1249 1267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">Zhang et al., 2000</xref>
###xml 1280 1300 1280 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">Gergely et al., 1999</xref>
###xml 1412 1431 1412 1431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">Avril et al., 2006a</xref>
###xml 264 269 <span type="species:ncbi:9606">Human</span>
###xml 488 493 <span type="species:ncbi:9606">human</span>
The Sia-recognizing Ig superfamily lectins (Siglecs) are a type-I transmembrane protein family, consisting of an N-terminal Sia-binding V-set domain and a variable number of extracellular C2-set domains (Varki and Angata, 2006; Crocker et al., 2007; Varki, 2007). Human CD33-related Siglecs (hCD33rSiglecs), comprising Siglecs 3, 5-11, XII, 14, and 16, are a rapidly evolving subgroup of Siglecs predominantly expressed on leukocytes (Crocker et al., 2007). The most prominent Siglecs on human monocyte/macrophages, neutrophils, and dendritic cells are Siglec-5 (hSiglec-5) and Siglec-9 (hSiglec-9), each of which contains two intracellular tyrosine-based signaling motifs (Crocker et al., 2007). The membrane-proximal motif (LHYASL) conforms to the canonical immunoreceptor tyrosine-based inhibitory motif (I/L/V)xYxx(L/V), whereas the distal motif (TEYSEI) resembles the immunoreceptor tyrosine-based switch motif (TXYXX[V/I]) found in the CD150/SLAM subfamily (Ravetch and Lanier, 2000). The immunoreceptor tyrosine-based inhibitory motif is present in various inhibitory receptors that antagonize kinase-dependent activation cascades (Taylor et al., 2000) and function by recruiting Src homology 2 domain-containing tyrosine phosphatases SHP-1 (Zhang et al., 2000) and SHP-2 (Gergely et al., 1999). Both hSiglec-5 and hSiglec-9 can recruit SHP-1 and SHP-2 and function as inhibitory receptors of leukocytes (Avril et al., 2006a).
###end p 3
###begin p 4
###xml 77 96 77 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Carlin et al., 2007</xref>
###xml 278 297 278 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Carlin et al., 2009</xref>
###xml 176 181 <span type="species:ncbi:9606">human</span>
###xml 628 633 <span type="species:ncbi:9606">human</span>
We recently demonstrated that GBS of different serotypes bind hCD33rSiglecs (Carlin et al., 2007) and that GBS serotype III engages Siglec-9 on the surface of cells, including human neutrophils, in a Sia- and Siglec-specific manner to down-regulate their immune responsiveness (Carlin et al., 2009). In this paper, we report the unexpected discovery that certain GBS strains bind hSiglec-5 in a Sia-independent manner, via a specific protein anchored to the bacterial cell wall. Using a combination of bacterial and immunological reagents, we characterize the protein-mediated interaction of GBS with Siglec-5 on the surface of human leukocytes and present functional evidence that it represents a novel bacterial immune evasion mechanism.
###end p 4
###begin title 5
RESULTS AND DISCUSSION
###end title 5
###begin title 6
GBS interacts with hSiglec-5-Fc through a trypsin-sensitive bacterial protein
###end title 6
###begin p 7
###xml 441 460 437 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Carlin et al., 2007</xref>
###xml 538 553 534 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1, A and B</xref>
###xml 748 756 740 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 909 917 901 909 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
We tested WT GBS isolates expressing sialylated CPS of serotypes Ia (strain A909) and III (strain COH1), isogenic Sia-negative mutants of each strain generated by allelic replacement of the CMP-Neu5Ac-synthase gene (DeltaNeuA), and GBS pretreated with trypsin to remove cell surface proteins, for binding to chimeras of hSiglec5 (hSiglec-5-Fc) and hSiglec-9 (hSiglec-9-Fc) by flow cytometry. Corroborating our previous ELISA-based findings (Carlin et al., 2007), serotype III GBS bound to hSiglec-9-Fc and serotype Ia bound to hSiglec-5 (Fig. 1, A and B). The GBS serotype III strain bound to hSiglec-9-Fc in a Sia-specific manner because this interaction was lost for the isogenic Sia-negative DeltaNeuA mutant but unaltered by trypsin treatment (Fig. 1 A). In contrast, attachment of the GBS serotype Ia strain to hSiglec-5-Fc was maintained in the Sia-deficient mutant and eliminated by trypsin treatment (Fig. 1 B), linking binding to a trypsin-sensitive protein rather than the anticipated sugar-lectin interaction.
###end p 7
###begin p 8
###xml 0 85 0 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The GBS &#946; protein mediates attachment to hSiglec-5-Fc in a Sia-independent manner.</bold>
The GBS beta protein mediates attachment to hSiglec-5-Fc in a Sia-independent manner. (A and B) WT GBS serotype III (A) and Ia (B) and their isogenic Sia-deficient DeltaNeuA mutants were incubated with hSiglec-9-Fc and hSiglec-5-Fc, respectively, followed by PE-conjugated secondary antibodies, and analyzed by flow cytometry for Sia-dependent binding of hSiglecs. Similar analysis was performed with WT GBS serotype III (A) and Ia (B) pretreated with or without trypsin to determine protein-dependent binding of hSiglecs. (C) Western blot analysis of GBS whole cell lysates from GBS serotype Ia and III DeltaNeuA mutants with hSiglec-Fc chimeras as probes. The analysis identified an approximately125-kD specific hSiglec-5 binding protein in the Ia strain. (D) Analysis of GBS extracts prepared under basic conditions (pH 9.7) also identified an approximately125-kD protein that binds hSiglec5. (E) AUS treatment (50 mU/ml for 2 h) does not affect binding of the 125-kD protein to hSiglec5. (F) WT GBS serotype Ia and isogenic mutant DeltaBac (lacking the beta protein), or the plasmid complemented mutant DeltaBac + pBac, were incubated with hSiglec-5-Fc and PE-conjugated secondary antibody and analyzed by flow cytometry. All experiments were performed in duplicate and repeated three (A and B) or four (C-F) times with similar results. Representative experiments are shown.
###end p 8
###begin title 9
The GBS beta protein interacts with hSiglec-5 in a Sia-independent manner
###end title 9
###begin p 10
###xml 726 734 722 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 1180 1200 1170 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Lindahl et al., 2005</xref>
###xml 1417 1437 1391 1411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">Lindahl et al., 1990</xref>
###xml 1626 1634 1600 1608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 D</xref>
###xml 1712 1736 1686 1710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arthrobacter ureafaciens</italic>
###xml 1790 1798 1764 1772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 E</xref>
###xml 2382 2385 2346 2349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bac</italic>
###xml 2478 2486 2442 2450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 F</xref>
###xml 514 519 <span type="species:ncbi:9606">human</span>
###xml 856 861 <span type="species:ncbi:9606">human</span>
###xml 1712 1736 <span type="species:ncbi:37931">Arthrobacter ureafaciens</span>
To identify the proteins responsible for mediating attachment to hSiglec-5, we prepared whole cell lysates of the GBS serotype Ia strain that bound hSiglec-5-Fc and, as a control, the nonbinding GBS serotype III strain. To avoid hSiglec-Fc Sia-specific interactions, isogenic DeltaNeuA mutants that were virtually devoid of detectable cell surface Sia () were used. Proteins were separated under reducing conditions by SDS-PAGE, transferred to a PVDF filter, and probed with hSiglec-Fc chimeras and secondary anti-human HRP-conjugated antibodies. The hSiglec-5-Fc chimera interacted with a GBS protein of an apparent molecular mass of 125 kD found in lysates of the GBS serotype Ia strain but not in the serotype III control (Fig. 1 C). The hSiglec-9-Fc chimera did not interact with this protein or any others, excluding nonspecific interactions with the human IgG-Fc portion of the chimeras. Based on size, surface location, sensitivity to trypsin, presence in the GBS serotype Ia strain, and absence in the GBS serotype III strain, we hypothesized that the protein mediating GBS interaction with hSiglec-5-Fc was the surface-expressed beta protein (also known as Bac or betaC; Lindahl et al., 2005). To produce a partially purified GBS beta protein extract, we incubated the GBS serotype Ia and serotype III (negative control) DeltaNeuA mutants at pH 9.7 for 4 h at 37degreesC, selectively releasing beta protein (Lindahl et al., 1990), concentrated and separated supernatants by SDS-PAGE, and then blotted and probed with hSiglec-5-Fc. This sample was highly enriched for the 125-kD protein interacting with hSiglec-5-Fc (Fig. 1 D). Treatment of the protein extract with active or heat-inactivated (control) Arthrobacter ureafaciens sialidase (AUS) did not change hSiglec-5-Fc binding (Fig. 1 E). To determine the identity of the 125-kD GBS protein, the band reacting with hSiglec-5-Fc was excised, digested, and analyzed using MALDI-TOF MS peptide fingerprinting (Fig. S1 B). The monoisotopic masses of the peptide fragments listed were analyzed using the online database at Rockefeller University () and the GBS beta protein was identified with 100% certainty. Confirming the significance of the observed interaction, an isogenic beta protein-deficient mutant (DeltaBac) of our parent GBS Ia strain lost the ability to bind hSiglec-5-Fc, but when it was complemented with the bac gene expressed on a plasmid vector (pBac), WT levels of hSiglec-5-Fc binding were restored (Fig. 1 F).
###end p 10
###begin title 11
The beta protein is required for GBS interactions with hSiglec-5 via its N-terminal domain
###end title 11
###begin p 12
###xml 153 175 150 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Areschoug et al., 2002</xref>
###xml 411 419 402 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
###xml 567 575 558 566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 653 661 644 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 775 783 766 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 C</xref>
###xml 842 860 833 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Heden et al., 1991</xref>
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 137 142 <span type="species:ncbi:9606">human</span>
###xml 913 919 <span type="species:ncbi:9557">baboon</span>
###xml 938 948 <span type="species:ncbi:9598">chimpanzee</span>
###xml 1086 1096 <span type="species:ncbi:9598">chimpanzee</span>
###xml 1167 1173 <span type="species:ncbi:9557">baboon</span>
The GBS beta protein N-terminal (cell wall distal) domain is known to bind human IgA-Fc, whereas its C-terminal domain can interact with human factor H (Areschoug et al., 2002). To map the domain for beta protein-hSiglec-5 interaction, we preincubated GBS with or without polyclonal antibodies against full-length beta protein (Beta Ab), its N-terminal domain (B6 Ab), or its C-terminal domain (75 kD antibody; Fig. 2 A). The Beta Ab and B6 Ab significantly blocked GBS binding to hSiglec-5-Fc, causing >75% (P < 0.001) and >95% (P < 0.001) inhibition, respectively (Fig. 2 B). In contrast, the 75-kD Ab did not interfere with GBS hSiglec-5-Fc binding (Fig. 2 B). Immunoblot confirmed that the N-terminal B6 domain, but not the 75-kD C-terminal fragment, bound hSiglec-5-Fc (Fig. 2 C). Note that recombinant B6 protein is size heterogeneous (Heden et al., 1991). Furthermore, GBS beta protein bound hSiglec-5 and baboon Siglec-5, but not chimpanzee Siglec 5 (), mapping beta protein binding to the hSiglec-5 V-set (lectin) domain because this domain contains all amino acid residues in chimpanzee Siglec-5 that differ from the hSiglec5 sequence but are not shared by baboon Siglec-5.
###end p 12
###begin p 13
###xml 0 139 0 136 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The N-terminal domain of the &#946; protein mediates hSiglec-5&#8211;Fc interactions and can promote GBS binding to CHO cells expressing hSiglec-5.</bold>
###xml 239 245 <span type="species:ncbi:9986">rabbit</span>
###xml 321 327 <span type="species:ncbi:9986">rabbit</span>
The N-terminal domain of the beta protein mediates hSiglec-5-Fc interactions and can promote GBS binding to CHO cells expressing hSiglec-5. (A) Schematic of the GBS beta protein, including the peptide fragments previously used to generate rabbit polyclonal antisera Beta, B6, and 75 kD. (B) WT GBS were preincubated with rabbit polyclonal antisera targeting various domains of the beta protein before addition of hSiglec-5-Fc, and analysis of hSiglec-5-Fc binding by flow cytometry. (C) Western blot analysis shows direct binding of Siglec-5 to the B6 region of the beta protein. (D) FITC-labeled GBS were allowed to adhere to CHO cells transfected with hSiglec-5 for 20 min and nonadherent GBS were removed by repeated washing. In blocking experiments, CHO cells were preincubated with anti-Siglec-5 antibody for 10 min. Bar, 100 microm. (E) To quantify GBS attachment to individual cells, CHO cell monolayers were lifted with PBS + 5 mM EDTA and analyzed by flow cytometry. All experiments repeated three (B, D, and E) or two (C) times with similar results. Images show pooled data (B and E) or a representative experiment (C and D). Error bars represent standard deviation. Statistical analysis was performed using one-way ANOVA with Tukey's post-test.
###end p 13
###begin title 14
GBS binding to cell surface-expressed hSiglec-5 is beta protein dependent
###end title 14
###begin p 15
###xml 365 373 359 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 D</xref>
###xml 581 589 571 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 D</xref>
###xml 721 729 711 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 D</xref>
###xml 851 859 841 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 E</xref>
###xml 1243 1251 1221 1229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 E</xref>
To determine if GBS beta protein could bind hSiglec-5 on a eukaryotic cell surface, we stably transfected CHO-K1 cells with an hSiglec-5 expression plasmid and applied FITC-labeled GBS to the monolayers. Nonadherent bacteria were washed away and fluorescent images of adherent GBS captured. WT GBS expressing beta protein adhered to CHO cells expressing hSiglec-5 (Fig. 2 D) but not to nontransfected cells (not depicted). In contrast, the DeltaBac mutant did not adhere to CHO cells expressing hSiglec5, and binding was restored upon mutant complementation with the pBac plasmid (Fig. 2 D). GBS attachment to transfected CHO cells was dependent on hSiglec-5, as anti-Siglec-5 antibody significantly blocked the binding (Fig. 2 D). Adherence was quantified by lifting the monolayers and analyzing single cells for adherent FITC-GBS by flow cytometry (Fig. 2 E). Adherent WT GBS or pBac-complemented DeltaBac mutant were present on the majority of cells, usually with more than one attached FITC-labeled bacterium per cell (greater shifts in fluorescence intensity). In contrast, very few DeltaBac mutant bacteria adhered to the CHO(hSiglec5) cells. Anti-Siglec-5 antibody reduced WT GBS binding to the level observed with the DeltaBac mutant (Fig. 2 E). We conclude that binding of GBS to the cell surface is a direct result of beta protein-mediated binding to hSiglec-5.
###end p 15
###begin title 16
###xml 73 78 <span type="species:ncbi:9606">human</span>
GBSs expressing beta protein colocalize with hSiglec-5 on the surface of human monocytes
###end title 16
###begin p 17
###xml 363 371 360 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 655 663 644 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
GBS-U937 monocyte interactions were visualized using fluorescent deconvolution microscopy with a hSiglec-5-specific antibody, a fluorescently tagged (red) secondary antibody to label hSiglec-5, and Hoechst DNA stain (blue) to visualize cell nuclei. WT GBS expressing beta protein colocalized with clear aggregations of hSiglec-5 present on the U937 cell surface (Fig. 3 A). Increased quantities of hSiglec-5 at the interface of the DeltaBac mutant and the U937 cell surface were not observed; consequently, the Manders coefficient for colocalization of bacteria and hSiglec-5 was significantly less in the DeltaBac mutant compared with the WT GBS strain (Fig. 3 A).
###end p 17
###begin p 18
###xml 0 403 0 397 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GBS expressing &#946; protein colocalize with hSiglec-5 on U937 leukocytes and neutrophils, increasing bacterial attachment but impairing their phagocytosis (A) Colocalization of FITC-WT GBS (green) with hSiglec 5 (red) on the cell surface of U937 cells (blue nuclei) not observed in parallel studies with the isogenic FITC-labeled &#946; protein&#8211;deficient mutant, as visualized by deconvolution microscopy.</bold>
###xml 580 585 <span type="species:ncbi:9606">human</span>
GBS expressing beta protein colocalize with hSiglec-5 on U937 leukocytes and neutrophils, increasing bacterial attachment but impairing their phagocytosis (A) Colocalization of FITC-WT GBS (green) with hSiglec 5 (red) on the cell surface of U937 cells (blue nuclei) not observed in parallel studies with the isogenic FITC-labeled beta protein-deficient mutant, as visualized by deconvolution microscopy. Bar, 5 microm. (B) FITC-labeled GBS were allowed to interact with U937 for 60 min at 4degreesC (to prevent phagocytosis). Adherence was measured by flow cytometry. (C) Primary human neutrophils were incubated with live GBS-FITC on ice to allow cell-cell interactions but block phagocytosis. The percentage of neutrophils with adherent bacteria was measured using flow cytometry. (D) To calculate phagocytic uptake of GBS, bacteria were added to U937 at MOI 10:1 for 30 min, washed, antibiotics added for 2 h to kill extracellular bacteria, and then cells lysed and dilutions plated to enumerate intracellular CFU. Where indicated, U937 cells were preincubated with anti-Siglec-5 Ab (1-A5) for 50 min, which results in endocytosis of the receptor, leaving approximately10% of original levels of Siglec-5 on the surface before addition of GBS. Horizontal bars represent the mean. Each experiment was performed in triplicate and repeated three times with similar results. Representative images (A) or pooled data (Manders coefficient; B-D) are shown. Error bars represent standard deviation. Statistical analysis was performed using one-way ANOVA with Tukey's post-test.
###end p 18
###begin title 19
beta protein binding to Siglec-5 promotes GBS leukocyte attachment but impairs phagocytosis
###end title 19
###begin p 20
###xml 163 171 153 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 B</xref>
###xml 206 214 196 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 C</xref>
###xml 577 585 557 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 D</xref>
###xml 942 950 906 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 D</xref>
###xml 187 192 <span type="species:ncbi:9606">human</span>
###xml 1005 1010 <span type="species:ncbi:9606">human</span>
In a binding experiment at 4degreesC to prevent phagocytosis, the WT GBS strain bound to a greater degree than did the isogenic DeltaBac mutant to U937 monocytes (Fig. 3 B, P = 0.01) and human neutrophils (Fig. 3 C, P < 0.001). To correlate binding to phagocytic uptake, we incubated bacteria with U937 monocytes for 30 min at 37degreesC, killed extracellular bacteria using antibiotics, and lysed monocytes to recover internalized bacteria for enumeration. U937 cells phagocytosed more DeltaBac mutant bacteria than either the WT GBS parent strain or the complemented mutant (Fig. 3 D, P < 0.001). Antibody cross-linking of Siglec-5 causes rapid endocytosis of the receptor so that only approximately5-10% remains on the cell surface after 45 min (unpublished data). Upon depletion of hSiglec-5 from the U937 cell surface using an anti-hSiglec-5 antibody, phagocytosis of WT GBS approached the levels seen with the isogenic DeltaBac mutant (Fig. 3 D). Thus, although GBSs expressing beta protein bind to human leukocytes more avidly, they are phagocytosed less efficiently, and this reduction depends on cell surface expression of hSiglec-5. Additional differential fluorescence studies to quantify phagocytosed versus extracellular adherent bacteria corroborate these observations (). A similar inhibitory effect of GBS beta protein expression on U937 cell phagocytosis was observed in serum-free assays, excluding any theoretical confounding effect of the beta protein binding to IgA (Fig. S3 C).
###end p 20
###begin title 21
beta protein expression can increase SHP recruitment to hSiglec-5
###end title 21
###begin p 22
###xml 383 391 379 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 554 562 538 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 864 872 840 848 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 999 1007 971 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 1105 1123 1074 1092 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lactococcus lactis</italic>
###xml 1226 1234 1195 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 1105 1123 <span type="species:ncbi:1358">Lactococcus lactis</span>
CD33rSiglecs mediate inhibitory signaling in immune cells via recruitment of SHP protein tyrosine phosphatases. We incubated the WT GBS strain and DeltaBac mutant with CHO cells expressing hSiglec-5, performed immunoprecipitation for hSiglec-5, and then probed for coimmunoprecipitation of tyrosine phosphatase SHP-2. SHP-2 was not recruited to hSiglec-5 in the absence of bacteria (Fig. 4 A). However, when CHO(hSiglec-5) cells were exposed to WT GBS, SHP-2 was recruited to hSiglec-5 beginning at approximately5 min and reached a maximum at 15-20 min (Fig. 4 A). In contrast, no recruitment of SHP-2 to hSiglec-5 on CHO(hSiglec-5) was detected after exposure to the GBS DeltaBac mutant. Similarly, U937 monocytes, which had no detectable SHP-2 associated with hSiglec-5 at baseline, showed recruitment of SHP-2 in response to WT GBS but not the DeltaBac mutant (Fig. 4 B). Recruitment of SHP-1 to Siglec 5 in U937 monocytes did not differ appreciably after exposure to the WT and DeltaBac strain (Fig. 4 B); however, when beta protein was expressed heterologously in a Sia-deficient acapsular strain of Lactococcus lactis, a contribution of the protein to recruitment of both SHP-2 and SHP-1 to hSiglec-5 could be detected (Fig. 4 B). The observed GBS beta protein-dependent SHP-2 recruitment to Siglec-5 resembles Sia-dependent recruitment of SHP-2 to hSiglec9 in U937 cells exposed to serotype III GBS ().
###end p 22
###begin p 23
###xml 0 97 0 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GBS &#946; protein effects on recruitment of SHP family protein tyrosine phosphatases to hSiglec-5.</bold>
###xml 406 415 397 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L. lactis</italic>
###xml 337 342 <span type="species:ncbi:9606">human</span>
###xml 406 415 <span type="species:ncbi:1358">L. lactis</span>
GBS beta protein effects on recruitment of SHP family protein tyrosine phosphatases to hSiglec-5. (A) SHP-2 recruitment to hSiglec-5 by coimmunoprecipitation studies in CHO cells transfected with hSiglec-5 and exposed to WT and beta protein-deficient GBS. (B) SHP-1 and SHP-2 recruitment to hSiglec-5 by coimmunoprecipitation studies in human U937 monocytes exposed to WT and beta protein-deficient GBS or L. lactis expressing the GBS beta protein or empty vector control. *N-glycans were removed using PNGase F before separation by SDS-PAGE in CHO cell experiments. All experiments performed three times with similar results. A representative experiment is shown.
###end p 23
###begin title 24
beta protein interferes with neutrophil activation and killing of GBS
###end title 24
###begin p 25
###xml 234 256 234 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">Brinkmann et al., 2004</xref>
###xml 297 316 297 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Carlin et al., 2007</xref>
###xml 602 610 595 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 A</xref>
###xml 650 658 643 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 B</xref>
###xml 704 712 697 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 C</xref>
###xml 868 876 857 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 D</xref>
###xml 1010 1018 996 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 E</xref>
###xml 737 742 <span type="species:ncbi:9606">human</span>
Recently, we reported that GBS serotype III mimicry of host Sias allowed engagement of hSiglec-9, leading to reduced neutrophil phagocytosis, diminished oxidative burst, and impaired formation of neutrophil extracellular traps (NETs; Brinkmann et al., 2004), together promoting pathogen survival (Carlin et al., 2007). In this study, we performed additional neutrophil studies to ascertain how the newly discovered GBS beta protein-mediated engagement of hSiglec-5 would affect these phagocyte functions. Compared with the isogenic DeltaBac mutant, the WT GBS strain elicited a weaker oxidative burst (Fig. 5 A), triggered the release of fewer NETs (Fig. 5 B), and stimulated less transcription of IL-8 (Fig. 5 C) upon coincubation with human neutrophils. Moreover, the WT GBS strain showed increased survival versus the DeltaBac mutant in a neutrophil killing assay (Fig. 5 D). Inhibition of beta protein engagement of hSiglec-5 with an anti-hSiglec-5 monoclonal antibody increased neutrophil killing of GBS (Fig. 5 E). These findings indicated that beta protein-expressing GBS strains can use this protein to suppress the innate immune function of phagocytic cells.
###end p 25
###begin p 26
###xml 0 67 0 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GBS &#946; protein effects on human neutrophil activation and killing</bold>
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 384 389 <span type="species:ncbi:9606">human</span>
###xml 483 488 <span type="species:ncbi:9606">human</span>
GBS beta protein effects on human neutrophil activation and killing. (A) Oxidative burst activity of neutrophils exposed to GBS WT, DeltaBac mutant, and complemented mutant strains. (B) Production of NETs in response to GBS WT, DeltaBac mutant, and complemented mutant strains. Bar, 50 microm. (C) Comparison of WT and DeltaBac mutant GBS strains in induction of IL-8 transcript from human neutrophils. (D and E) Survival of GBS WT and DeltaBac mutant strains upon coincubation with human neutrophils (D), with or without coincubation with anti-Siglec-5 Ab or control Ab (E). All experiments performed in triplicate and repeated three (A-C and E) or two (D) times with similar results. A representative experiment (A, C, and D) or pooled data (B and E) are shown. The error bars represent mean value +/- SD.
###end p 26
###begin title 27
Protein-mediated Siglec engagement and GBS immune evasion
###end title 27
###begin p 28
###xml 217 239 214 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Neisseria meningitidis</italic>
###xml 244 264 241 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Campylobacter jejuni</italic>
###xml 345 363 342 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">Jones et al., 2003</xref>
###xml 365 384 362 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib4">Avril et al., 2006b</xref>
###xml 386 405 383 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Carlin et al., 2007</xref>
###xml 512 531 509 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Carlin et al., 2007</xref>
###xml 1000 1022 994 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">Oldenborg et al., 2001</xref>
###xml 1024 1041 1018 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">Kant et al., 2002</xref>
###xml 200 205 <span type="species:ncbi:9606">human</span>
###xml 217 239 <span type="species:ncbi:487">Neisseria meningitidis</span>
###xml 244 264 <span type="species:ncbi:197">Campylobacter jejuni</span>
The beta protein is the first example of a protein other than an antibody that directly engages the extracellular domains of an hCD33rSiglec in a Sia-independent manner. Previously, GBS and two other human pathogens, Neisseria meningitidis and Campylobacter jejuni, were shown to interact with hCD33r-Siglecs through cell surface-expressed Sia (Jones et al., 2003; Avril et al., 2006b; Carlin et al., 2007) and, in the case of GBS, these Sia-dependent interactions served to down-regulate neutrophil activation (Carlin et al., 2007). GBS association with hSiglec-5 in a protein-dependent manner reveals a novel mechanism by which pathogens may co-opt hCD33rSiglecs to their advantage. beta protein-mediated engagement causes an accumulation of Siglec-5 at the sight of GBS contact and increases the recruitment of SHP protein tyrosine phosphatases to the receptor's cytosolic tail. Association of SHP family phosphatases with surface receptors can negatively regulate receptor-mediated phagocytosis (Oldenborg et al., 2001; Kant et al., 2002). Likewise, the antiphagocytic effect described in this paper is mediated by beta protein-expressing GBS only when Siglec-5 is present on the leukocyte surface and, thus, likely depends on SHP recruitment to the surface receptor.
###end p 28
###begin p 29
###xml 197 217 194 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">Lindahl et al., 2005</xref>
###xml 353 372 347 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">Nagano et al., 2002</xref>
###xml 499 521 490 512 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Areschoug et al., 2002</xref>
###xml 656 675 644 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">Pleass et al., 2001</xref>
###xml 735 749 723 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">Pangburn, 2000</xref>
###xml 898 918 886 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">Crocker et al., 2007</xref>
###xml 436 441 <span type="species:ncbi:9606">human</span>
The GBS beta protein is a large antigenic surface-anchored protein expressed in almost all GBS serotype Ib strains and some serotype Ia, II, and V strains but almost never in serotype III strains (Lindahl et al., 2005). Recently, it was shown that high levels of beta protein expression are associated with increased virulence of GBS clinical isolates (Nagano et al., 2002). beta protein is known to interact with two components of the human immune system, the Fc portion of serum IgA and factor H (Areschoug et al., 2002), and our present finding that beta protein binds to hSiglec-5 identifies a third such interaction. Through nonimmune binding of IgA (Pleass et al., 2001), engagement of factor H (a major regulator of complement; Pangburn, 2000), and, now, attachment to hSiglec5, which is proposed to play an important role in regulating phagocyte function and the link to cellular immunity (Crocker et al., 2007), beta protein appears to be a multifunctional virulence factor capable of interfering with several aspects of host defense to bacterial infection.
###end p 29
###begin p 30
###xml 318 340 315 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">Varki and Angata, 2006</xref>
We have shown that GBS is able to engage different CD33rSiglecs using its sialylated CPS or the beta protein. The Sia-binding sites of hCD33rSiglecs are rapidly evolving, a process that is hypothesized to be likely to facilitate continual host Sia self-recognition in the face of rapid changes in host Sia expression (Varki and Angata, 2006). In this scenario, rapid evolution of the host sialome, driven by Sia-binding pathogens such as malaria and influenza, requires that the CD33rSiglecs also evolve rapidly to keep up with recognizing self. If GBS CPS Sias have evolved to engage inhibitory CD33rSiglecs, then these Sias would need to coevolve with the rapidly changing Sia-binding specificities of CD33rSiglecs to maintain functional interactions. The parallel evolution by GBS of a protein ligand that allows functional engagement of hSiglec-5 may have facilitated continued success of CPS serotypes (e.g., type Ia) that had lost their original binding affinity to host Siglec-5.
###end p 30
###begin p 31
###xml 202 207 <span type="species:ncbi:9606">human</span>
In sum, we demonstrate the presence of a microbial protein ligand that engages a member of the hCD33rSiglecs and find that this interaction increases bacterial resistance to phagocytosis and killing by human leukocytes. Recent studies suggest that Sia-expressing pathogenic microorganisms may use cell surface Sias to bind hCD33rSiglecs to dampen innate immune responses. Our present findings indicate that this pathogenic mechanism may not be limited to Sia-expressing microorganisms and, thus, may represent a more widespread strategy of microbial immune evasion.
###end p 31
###begin title 32
MATERIALS AND METHODS
###end title 32
###begin title 33

###end title 33
###begin title 34
Bacteria, growth conditions, and labeling.
###end title 34
###begin p 35
###xml 253 275 245 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Areschoug et al., 2002</xref>
###xml 277 295 269 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">Lewis et al., 2004</xref>
###xml 297 301 289 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">2007</xref>
###xml 410 429 402 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Carlin et al., 2007</xref>
###xml 586 605 572 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Carlin et al., 2007</xref>
###xml 90 95 <span type="species:ncbi:9606">human</span>
GBS WT strains of serotypes Ia (A909) and III (COH1) are well-characterized isolates from human neonates with invasive infections. Generation of the DeltaNeuA and DeltaBac mutants and complemented mutants of A909 and COH1 have been previously reported (Areschoug et al., 2002; Lewis et al., 2004, 2007). GBS were grown and prepared for assays including sialidase and trypsin treatment as previously described (Carlin et al., 2007). Live GBS were incubated in PBS + 0.1% FITC (Sigma-Aldrich) at 37degreesC for 20 min; alternatively, heat-killed GBS were labeled as previously described (Carlin et al., 2007).
###end p 35
###begin title 36
Siglec-Fc binding assays.
###end title 36
###begin p 37
###xml 59 81 59 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">Angata and Varki, 2000</xref>
###xml 128 129 128 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o</sup>
###xml 348 366 341 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">Heden et al., 1991</xref>
###xml 368 390 361 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">Areschoug et al., 2002</xref>
###xml 407 408 400 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o</sup>
###xml 282 288 <span type="species:ncbi:9986">rabbit</span>
hSiglec-Fc chimeras were produced as previously described (Angata and Varki, 2000). GBSs were resuspended in RPMI + 10% FCS at 4oC with 10 microg/ml hSiglec-Fc, fluorescent secondary Ab, and analyzed by flow cytometry. In blocking experiments, GBS were preincubated with polyclonal rabbit anti-beta protein antibodies (Beta antibody, B6, or 75 kD; Heden et al., 1991; Areschoug et al., 2002) for 20 min at 4oC.
###end p 37
###begin title 38
GBS protein isolation, purification, and Western blots.
###end title 38
###begin p 39
###xml 580 613 567 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">Stalhammar-Carlemalm et al., 1993</xref>
GBS were washed and disrupted in lysis buffer with multiple freeze-thaw cycles, and extracts were centrifuged at 4degreesC. Supernatants were concentrated with Amicon Ultra-10 (Millipore), separated by SDS-PAGE under reducing conditions, and either stained with GelCode blue (Thermo Fisher Scientific) or transferred to PVDF, blocked, probed with 5 microg/ml Siglec-Fc chimeras and HRP-conjugated secondary Ab, and then detected with ECL reagent (Thermo Fisher Scientific). Partial purification of the beta protein was performed with slight modifications as previously described (Stalhammar-Carlemalm et al., 1993). GBS were incubated in 50 mM Tris, pH 9.7, at 37degreesC and supernatants concentrated with Microcon 30 (Millipore), separated, and probed with Siglec-Fc chimeras.
###end p 39
###begin title 40
Mammalian protein isolation and Western blots.
###end title 40
###begin p 41
###xml 172 177 <span type="species:ncbi:9606">human</span>
###xml 441 447 <span type="species:ncbi:9986">rabbit</span>
###xml 496 502 <span type="species:ncbi:9986">rabbit</span>
Cells were infected with GBS, washed, and lysed with 4degreesC TBS lysis buffer. Protein concentrations were normalized and immunoprecipitation was performed with 1A5 anti-human Siglec-5 antibody (gift from P. Crocker, University of Dundee, Dundee, Scotland, UK) and protein G Sepharose beads (4 fast flow; BD). Proteins were separated by reducing SDS-PAGE, transferred to PVDF, and probed with anti-Siglec-5 antibody BAF1072 (R&D systems), rabbit anti-SHP-1 (Santa Cruz Biotechnology, Inc.), or rabbit anti-SHP-2 (Millipore) and appropriate HRP-conjugated secondary Abs (Bio-Rad Laboratories) and ECL reagent (Thermo Fisher Scientific). U937 cells were resuspended in RPMI + 0.5% FCS overnight before assays. For assays using CHO cells, N-glycans were removed using PNGase F before separation by SDS-PAGE.
###end p 41
###begin title 42
GBS adherence and phagocytosis assays.
###end title 42
###begin p 43
###xml 66 85 66 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Carlin et al., 2007</xref>
###xml 111 116 <span type="species:ncbi:9606">human</span>
###xml 362 367 <span type="species:ncbi:9606">human</span>
CHO cell adherence assays were performed as described previously (Carlin et al., 2007). FITC-GBS were added to human leukocytes at 4degreesC in RPMI + 10% FCS, centrifuged to initiate contact, and rotated at 4degreesC for 30 min before analysis of adherence by flow cytometry. Phagocytosis assays were performed with or without preincubation in heat-inactivated human serum (HIHS). GBS MOI 10:1 were added to U937 cells and incubated at 37degreesC for 30 min before adding 5 microg/ml of penicillin and 100 microg/ml of gentamicin for 2 h to kill extracellular bacteria. Cells were washed and lysed and intracellular bacteria were enumerated using serial dilution plating. In specific assays, U937 cells were depleted of cell surface Siglec-5 by preincubation with 2 microl/ml of anti-Siglec-5 1A5 Ab for 50 min at 37degreesC in RPMI before adding GBS.
###end p 43
###begin title 44
GBS U937 cell deconvolution microscopy.
###end title 44
###begin p 45
###xml 482 501 476 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Carlin et al., 2007</xref>
###xml 765 766 753 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
Live FITC-GBS were added to U937 cells in HBSS MOI 5:1, incubated at 37degreesC for 10 min, washed, and resuspended in ice cold PBS + 1% BSA. Siglec-5 was labeled with 1A5 Ab and Alexa Fluor 647-conjugated secondary Ab (Invitrogen). Cells were fixed in 2% paraformaldehyde, spun onto poly-lysine-coated coverslips, and mounted in Prolong Gold with DAPI (Invitrogen). At least five images of GBS interactions were captured from three independent experiments as previously described (Carlin et al., 2007). Image Pro Plus software was used to determine Manders coefficients for green (GBS) colocalization with red (hSiglec-5) for every bacterial-cell interaction captured. The mean +/- SEM of WT and DeltaBac GBS were graphed and P-value was determined by a Student's t test.
###end p 45
###begin title 46
Neutrophil functional assays.
###end title 46
###begin p 47
###xml 57 76 57 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">Carlin et al., 2007</xref>
###xml 226 244 226 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">Carlin et al. 2009</xref>
###xml 627 628 621 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 953 958 <span type="species:ncbi:9606">Human</span>
Human neutrophils were prepared as previously described (Carlin et al., 2007) using Polymorphprep solution (Axis-Shield PoC AS) according to the manufacturer's instructions. Experiments were performed as previously described (Carlin et al. 2009) with minor modifications. IL-8 transcript was assessed by quantitative real-time RT-PCR. GBS were incubated in HBSS + 10% HIHS for 20 min at 37degreesC and added to neutrophils at MOI of 10:1 in HBSS + 2% HIHS final concentration and incubated for 10 min (oxidative burst) or 30 min (NETs) before analysis. GBS were added and the bacteria and neutrophils were spun together at 500 g for 5 min to initiate the assay. For neutrophil killing assays performed in the presence of antibodies, 5 microg/ml of anti-Siglec-5 Ab (clone 194128; R&D Systems) or IgG1 control (Sigma-Aldrich) Ab was added to purified neutrophils 2 min before the assay. Protocols were approved by the University of California, San Diego Human Research Protection Program.
###end p 47
###begin title 48
Online supplemental material.
###end title 48
###begin p 49
###xml 168 173 <span type="species:ncbi:9606">human</span>
###xml 178 184 <span type="species:ncbi:9557">baboon</span>
###xml 202 212 <span type="species:ncbi:9598">chimpanzee</span>
###xml 274 279 <span type="species:ncbi:9606">human</span>
Fig. S1 shows analysis of GBS surface Sia expression and mass spectrometric identification of GBS beta protein. Fig. S2 shows that GBS-expressing beta protein binds to human and baboon Siglec-5 but not chimpanzee Siglec-5. Fig. S3 corroborates that GBS beta protein impairs human monocyte phagocytosis in an hSiglec-5-dependent manner and under serum-free conditions. Fig. S4 shows that GBS serotype III Sia promotes recruitment of SHP-2 protein tyrosine phosphatases to hSiglec-9. Online supplemental material is available at .
###end p 49
###begin title 50
Supplementary Material
###end title 50
###begin title 51
[Supplemental Material]
###end title 51
###begin p 52
We would like to thank Kersi Pestonjamasp for work with the University of California, San Diego (UCSD) Cancer Center Digital Imaging Shared Resource, Colin McGinn for assistance with the Visualization Portal at the UCSD Supercomputer Center, and Paul Crocker for providing the anti-Siglec-5 antibody (1A5) supernatants.
###end p 52
###begin p 53
This work was supported by National Institutes of Health awards R01-HD051796 (V. Nizet) and P01-HL57345 (A. Varki), an American Heart Association Established Investigator Award (V. Nizet), and a grant from the Swedish Research Council (G. Lindahl).
###end p 53
###begin p 54
The authors have no conflicting financial interests.
###end p 54
###begin article-title 55
Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways.
###end article-title 55
###begin article-title 56
###xml 58 63 <span type="species:ncbi:9606">human</span>
Streptococcal beta protein has separate binding sites for human factor H and IgA-Fc.
###end article-title 56
###begin article-title 57
Negative regulation of leucocyte functions by CD33-related siglecs.
###end article-title 57
###begin article-title 58
###xml 115 135 115 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Campylobacter jejuni</italic>
###xml 115 135 <span type="species:ncbi:197">Campylobacter jejuni</span>
Sialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharides.
###end article-title 58
###begin article-title 59
Neutrophil extracellular traps kill bacteria.
###end article-title 59
###begin article-title 60
###xml 99 104 <span type="species:ncbi:9606">human</span>
Group B streptococcal capsular sialic acids interact with siglecs (immunoglobulin-like lectins) on human leukocytes.
###end article-title 60
###begin article-title 61
Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response.
###end article-title 61
###begin article-title 62
Siglecs and their roles in the immune system.
###end article-title 62
###begin article-title 63
###xml 22 43 <span type="species:ncbi:1319">group B streptococcus</span>
A history of neonatal group B streptococcus with its related morbidity and mortality rates in the United States.
###end article-title 63
###begin article-title 64
Immunoreceptor tyrosine-based inhibition motif-bearing receptors regulate the immunoreceptor tyrosine-based activation motif-induced activation of immune competent cells.
###end article-title 64
###begin article-title 65
Molecular characterization of an IgA receptor from group B streptococci: sequence of the gene, identification of a proline-rich region with unique structure and isolation of N-terminal fragments with IgA-binding capacity.
###end article-title 65
###begin article-title 66
Recognition of sialylated meningococcal lipopolysaccharide by Siglecs expressed on myeloid cells leads to enhanced bacterial uptake.
###end article-title 66
###begin article-title 67
SHP-1 regulates Fcgamma receptor-mediated phagocytosis and the activation of RAC.
###end article-title 67
###begin article-title 68
###xml 71 84 71 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus</italic>
Discovery and characterization of sialic acid O-acetylation in group B Streptococcus.
###end article-title 68
###begin article-title 69
###xml 91 104 91 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus</italic>
NeuA O-acetylesterase activity modulates O-acetylation of capsular sialic acids in group B Streptococcus.
###end article-title 69
###begin article-title 70
Characterization of an IgA receptor from group B streptococci: specificity for serum IgA.
###end article-title 70
###begin article-title 71
###xml 20 44 20 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus agalactiae</italic>
###xml 20 44 <span type="species:ncbi:1311">Streptococcus agalactiae</span>
Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens.
###end article-title 71
###begin article-title 72
Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci.
###end article-title 72
###begin article-title 73
High expression of a C protein beta antigen gene among invasive strains from certain clonally related groups of type Ia and Ib group B streptococci.
###end article-title 73
###begin article-title 74
CD47-signal regulatory protein alpha (SIRPalpha) regulates Fcgamma and complement receptor-mediated phagocytosis.
###end article-title 74
###begin article-title 75
Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement.
###end article-title 75
###begin article-title 76
Glycoconjugate vaccines to prevent group B streptococcal infections.
###end article-title 76
###begin article-title 77
###xml 112 117 <span type="species:ncbi:9606">human</span>
Streptococcal IgA-binding proteins bind in the Calpha2-Calpha3 interdomain region and inhibit binding of IgA to human CD89.
###end article-title 77
###begin article-title 78
Immune inhibitory receptors.
###end article-title 78
###begin article-title 79
Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections.
###end article-title 79
###begin article-title 80
Paired inhibitory and activating receptor signals.
###end article-title 80
###begin article-title 81
Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins.
###end article-title 81
###begin article-title 82
Siglecs-the major subfamily of I-type lectins.
###end article-title 82
###begin article-title 83
Definition of a bacterial virulence factor: sialylation of the group B streptococcal capsule.
###end article-title 83
###begin article-title 84
Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling.
###end article-title 84
###begin p 85
###xml 25 49 25 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arthrobacter ureafaciens</italic>
###xml 104 117 104 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Streptococcus</italic>
###xml 25 49 <span type="species:ncbi:37931">Arthrobacter ureafaciens</span>
###xml 133 138 <span type="species:ncbi:9606">human</span>
###xml 183 188 <span type="species:ncbi:9606">human</span>
Abbreviations used: AUS, Arthrobacter ureafaciens sialidase; CPS, capsular polysaccharide; GBS, group B Streptococcus; hCD33rSiglec, human CD33-related Siglec; HIHS, heat-inactivated human serum; NET, neutrophil extracellular trap; Sia, sialic acid; Siglec, Sia-recognizing Ig superfamily lectin.
###end p 85

